Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Finn

Showing results (31-40 of 407) with videos related to

Pageof 41
Sort By:
Biotherapy (Dordrecht, Netherlands)|January 1, 1992
Antigen-specific, MHC-unrestricted T cellsO J Finn
The Journal of Experimental Medicine|November 26, 2003
Premalignant lesions as targets for cancer vaccinesOlivera J Finn
The New England Journal of Medicine|March 19, 2010
Pleurodynia; preliminary note on an epidemic in BostonJ J FINN
Current Opinion in Immunology|October 1, 1993
Tumor-rejection antigens recognized by T lymphocytesO J Finn
The New England Journal of Medicine|September 24, 2005
Immune response as a biomarker for cancer detection and a lot moreOlivera J Finn
Immunological Reviews|March 28, 2008
Tumor immunology top 10 listOlivera J Finn
Clinical Immunology and Immunopathology|June 1, 1994
Tumor-specific immune responses and opportunities for tumor vaccinesO J Finn
Important Advances in Oncology|January 1, 1992
Pancreatic tumor antigens: diagnostic markers and targets for immunotherapyO J Finn
Current Opinion in Immunology|March 17, 2004
Tumor immunology at the service of cancer immunotherapyOlivera J Finn
Journal of Immunology (Baltimore, Md. : 1950)|February 22, 2007
Human tumor immunology at the molecular divideOlivera J Finn
Pageof 41

Showing results (31-40 of 407) with videos related to

Sort By:
Pageof 41
Biotherapy (Dordrecht, Netherlands)|January 1, 1992
Antigen-specific, MHC-unrestricted T cellsO J Finn
The Journal of Experimental Medicine|November 26, 2003
Premalignant lesions as targets for cancer vaccinesOlivera J Finn
The New England Journal of Medicine|March 19, 2010
Pleurodynia; preliminary note on an epidemic in BostonJ J FINN
Current Opinion in Immunology|October 1, 1993
Tumor-rejection antigens recognized by T lymphocytesO J Finn
The New England Journal of Medicine|September 24, 2005
Immune response as a biomarker for cancer detection and a lot moreOlivera J Finn
Immunological Reviews|March 28, 2008
Tumor immunology top 10 listOlivera J Finn
Clinical Immunology and Immunopathology|June 1, 1994
Tumor-specific immune responses and opportunities for tumor vaccinesO J Finn
Important Advances in Oncology|January 1, 1992
Pancreatic tumor antigens: diagnostic markers and targets for immunotherapyO J Finn
Current Opinion in Immunology|March 17, 2004
Tumor immunology at the service of cancer immunotherapyOlivera J Finn
Journal of Immunology (Baltimore, Md. : 1950)|February 22, 2007
Human tumor immunology at the molecular divideOlivera J Finn
Pageof 41